Kainos Medicine Stock Current Valuation
| 284620 Stock | 3,170 275.00 9.50% |
Valuation analysis of Kainos Medicine helps investors to measure Kainos Medicine's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Kainos Medicine's price fluctuation is very steady at this time. Calculation of the real value of Kainos Medicine is based on 3 months time horizon. Increasing Kainos Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Kainos Medicine is useful when determining the fair value of the Kainos stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kainos Medicine. Since Kainos Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kainos Stock. However, Kainos Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3170.0 | Real 3153.6 | Hype 3170.0 | Naive 3772.42 |
The real value of Kainos Stock, also known as its intrinsic value, is the underlying worth of Kainos Medicine Company, which is reflected in its stock price. It is based on Kainos Medicine's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Kainos Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kainos Medicine's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kainos Medicine helps investors to forecast how Kainos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kainos Medicine more accurately as focusing exclusively on Kainos Medicine's fundamentals will not take into account other important factors: Kainos Medicine Company Current Valuation Analysis
Kainos Medicine's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Kainos Medicine Current Valuation | 17.74 B |
Most of Kainos Medicine's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kainos Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Kainos Medicine has a Current Valuation of 17.74 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
Kainos Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kainos Medicine's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kainos Medicine could also be used in its relative valuation, which is a method of valuing Kainos Medicine by comparing valuation metrics of similar companies.Kainos Medicine is currently under evaluation in current valuation category among related companies.
Kainos Fundamentals
| Return On Equity | -57.31 | |||
| Current Valuation | 17.74 B | |||
| Shares Outstanding | 5.4 M | |||
| Shares Owned By Insiders | 25.33 % | |||
| Shares Owned By Institutions | 0.14 % | |||
| Revenue | 1.66 B | |||
| Net Income | (16.23 B) | |||
| Cash And Equivalents | 23.23 B | |||
| Total Debt | 1.63 B | |||
| Cash Flow From Operations | (9.2 B) | |||
| Market Capitalization | 31.27 B | |||
| Total Asset | 41.96 B | |||
| Z Score | 11.4 | |||
| Net Asset | 41.96 B |
About Kainos Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kainos Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kainos Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kainos Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Kainos Medicine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Kainos Medicine information on this page should be used as a complementary analysis to other Kainos Medicine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Kainos Stock analysis
When running Kainos Medicine's price analysis, check to measure Kainos Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kainos Medicine is operating at the current time. Most of Kainos Medicine's value examination focuses on studying past and present price action to predict the probability of Kainos Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kainos Medicine's price. Additionally, you may evaluate how the addition of Kainos Medicine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |